Shanghai Obio Technology (Group) Corp., Ltd., a biotechnology company, engages in the provision of technical services for the field of regenerative medicine and...
Junshi receives China’s NMPA acceptance for toripalimab injection
OBiO Tech: Net loss of 105 million yuan in the first half of 2025, a year-on-year narrowing
OBiO Tech plans to promote a restricted stock incentive plan of 3.7454 million shares
Zhengzhou Airport Economic Zone in Henan and OBiO Tech have strategic cooperation plans to build a "cell factory" and pilot the development of the cell gene therapy industry
OBiO Tech shareholder Huairuishengyin and its concerted parties plan to reduce their holdings by no more than 1%
CRO concept stocks fluctuate and strengthen, PR rises over 10%